Magnolia Research Group, Inc. — Ocala, Florida

Magnolia Research Group, Inc. is a clinical research site located in Ocala, Florida, United States 34471-5117.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Magnolia Research Group, Inc. has participated in 2 clinical trials.

Therapeutic areas: Arthritis, Rheumatoid, Keratoconjunctivitis Sicca.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Magnolia Research Group, Inc.?

Magnolia Research Group, Inc. has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Magnolia Research Group, Inc. conducted?

Magnolia Research Group, Inc. has 2 clinical trials on record. Their work covers Arthritis, Rheumatoid, Keratoconjunctivitis Sicca.

Is Magnolia Research Group, Inc. accredited by Crixeo Health?

Magnolia Research Group, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Magnolia Research Group, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.